Cigna Investments’s Altimmune ALT Stock Holding History

Cigna Investments’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-1,011	Closed	-$246K	–	838
2017 Q1	$246K	Buy	1,011 +912	+921%	+$488K	0.02%	648
2016 Q4	$96K	Buy	+99	New	+$88.7K	0.01%	697

Other funds holding ALT

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Quadrant Glendale, California $18M AUM 24.2% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Cigna Investments's ALT Position: Q2 2017 in Review

Cigna Investments sold out of Altimmune (ALT) in Q2 2017, closing a stake of 1,011 shares — an estimated $246K sold.

Cigna Investments first reported a position in ALT in Q4 2016 and held it in 2 quarters. The position peaked at $246K in Q1 2017. 41 funds tracked by Wall St. Rank hold ALT as of Q2 2017.

Cigna Investments reported no remaining Altimmune position as of Q2 2017 after selling out during the quarter.
Cigna Investments sold 1,011 Altimmune shares in Q2 2017, an estimated $246K.
Cigna Investments first reported a position in Altimmune in Q4 2016 and held it in 2 quarters.
Cigna Investments's Altimmune position peaked at $246K in Q1 2017.
41 funds tracked by Wall St. Rank held Altimmune as of Q2 2017.

Based on Cigna Investments's 13F filing for Q2 2017, filed 1 Aug 2017.